169 related articles for article (PubMed ID: 38506227)
21. Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells.
Shiozawa M; Chang CH; Huang YC; Chen YC; Chi MS; Hao HC; Chang YC; Takeda S; Chi KH; Wang YS
BMC Immunol; 2018 Aug; 19(1):27. PubMed ID: 30075754
[TBL] [Abstract][Full Text] [Related]
22. Carcinoembryonic antigen-producing cell-specific oncolytic adenovirus, OV798, for colorectal cancer therapy.
Li Y; Chen Y; Dilley J; Arroyo T; Ko D; Working P; Yu DC
Mol Cancer Ther; 2003 Oct; 2(10):1003-9. PubMed ID: 14578465
[TBL] [Abstract][Full Text] [Related]
23. Texture analysis of (125)I-A5B7 anti-CEA antibody SPECT differentiates metastatic colorectal cancer model phenotypes and anti-vascular therapy response.
Rajkumar V; Goh V; Siddique M; Robson M; Boxer G; Pedley RB; Cook GJ
Br J Cancer; 2015 Jun; 112(12):1882-7. PubMed ID: 25989271
[TBL] [Abstract][Full Text] [Related]
24. Combination of antibody targeting and PTD-mediated intracellular toxin delivery for colorectal cancer therapy.
Shin MC; Zhang J; Ah Min K; Lee K; Moon C; Balthasar JP; Yang VC
J Control Release; 2014 Nov; 194():197-210. PubMed ID: 25204286
[TBL] [Abstract][Full Text] [Related]
25. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.
Boogerd LSF; Hoogstins CES; Schaap DP; Kusters M; Handgraaf HJM; van der Valk MJM; Hilling DE; Holman FA; Peeters KCMJ; Mieog JSD; van de Velde CJH; Farina-Sarasqueta A; van Lijnschoten I; Framery B; Pèlegrin A; Gutowski M; Nienhuijs SW; de Hingh IHJT; Nieuwenhuijzen GAP; Rutten HJT; Cailler F; Burggraaf J; Vahrmeijer AL
Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):181-191. PubMed ID: 29361435
[TBL] [Abstract][Full Text] [Related]
26. Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer.
Kaushal S; McElroy MK; Luiken GA; Talamini MA; Moossa AR; Hoffman RM; Bouvet M
J Gastrointest Surg; 2008 Nov; 12(11):1938-50. PubMed ID: 18665430
[TBL] [Abstract][Full Text] [Related]
27. Carcinoembryonic antigen directed herpes viral oncolysis improves selectivity and activity in colorectal cancer.
Reinblatt M; Pin RH; Fong Y
Surgery; 2004 Sep; 136(3):579-84. PubMed ID: 15349105
[TBL] [Abstract][Full Text] [Related]
28. Impact of CEA-targeting Nanoparticles for Drug Delivery in Colorectal Cancer.
Sousa AR; Oliveira MJ; Sarmento B
J Pharmacol Exp Ther; 2019 Sep; 370(3):657-670. PubMed ID: 30670480
[TBL] [Abstract][Full Text] [Related]
29. Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers.
Garambois V; Glaussel F; Foulquier E; Ychou M; Pugnière M; Luo RX; Bezabeh B; Pèlegrin A
BMC Cancer; 2004 Oct; 4():75. PubMed ID: 15488142
[TBL] [Abstract][Full Text] [Related]
30. Physiologically Based Modeling of the Pharmacokinetics of "Catch-and-Release" Anti-Carcinoembryonic Antigen Monoclonal Antibodies in Colorectal Cancer Xenograft Mouse Models.
Polli JR; Engler FA; Balthasar JP
J Pharm Sci; 2019 Jan; 108(1):674-691. PubMed ID: 30321546
[TBL] [Abstract][Full Text] [Related]
31. Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using
de Gooyer JM; Elekonawo FMK; Bos DL; van der Post RS; Pèlegrin A; Framery B; Cailler F; Vahrmeijer AL; de Wilt JHW; Rijpkema M
Clin Cancer Res; 2020 Nov; 26(22):5934-5942. PubMed ID: 32900795
[TBL] [Abstract][Full Text] [Related]
32. Novel Carcinoembryonic-Antigen-(CEA)-Specific Pretargeting System to Assess Tumor Cell Viability after Irradiation of Colorectal Cancer Cells.
Meller B; Rave-Fränck M; Breunig C; Schirmer M; Baehre M; Nadrowitz R; Liersch T; Meller J
Strahlenther Onkol; 2011 Feb; 187(2):120-6. PubMed ID: 21271227
[TBL] [Abstract][Full Text] [Related]
33. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
Cai W; Olafsen T; Zhang X; Cao Q; Gambhir SS; Williams LE; Wu AM; Chen X
J Nucl Med; 2007 Feb; 48(2):304-10. PubMed ID: 17268029
[TBL] [Abstract][Full Text] [Related]
34. Chlorin Nanoparticles for Tissue Diagnostics and Photodynamic Therapy.
Scalfi-Happ C; Zhu Z; Graefe S; Wiehe A; Ryabova A; Loschenov V; Wittig R; Steiner RW
Photodiagnosis Photodyn Ther; 2018 Jun; 22():106-114. PubMed ID: 29567384
[TBL] [Abstract][Full Text] [Related]
35. Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
Lwin TM; Turner MA; Amirfakhri S; Nishino H; Debie P; Cosman BC; Hoffman RM; Hernot S; Bouvet M
J Surg Oncol; 2021 Dec; 124(7):1121-1127. PubMed ID: 34309885
[TBL] [Abstract][Full Text] [Related]
36. EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer.
Li Y; Du Y; Liang X; Sun T; Xue H; Tian J; Jin Z
Nanoscale; 2018 Sep; 10(35):16738-16749. PubMed ID: 30156250
[TBL] [Abstract][Full Text] [Related]
37. ZKSCAN3 Facilitates Liver Metastasis of Colorectal Cancer Associated with CEA-expressing Tumor.
Kim CW; Roh SA; Tak KH; Koh BM; Ha YJ; Cho DH; Kim SY; Kim YS; Kim JC
Anticancer Res; 2016 May; 36(5):2397-406. PubMed ID: 27127149
[TBL] [Abstract][Full Text] [Related]
38. Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer.
Vassileva V; Rajkumar V; Mazzantini M; Robson M; Badar A; Sharma S; Årstad E; Hochhauser D; Lythgoe MF; Kinghorn J; Boxer GM; Pedley RB
J Nucl Med; 2015 Aug; 56(8):1239-45. PubMed ID: 26045312
[TBL] [Abstract][Full Text] [Related]
39. Photochemical internalization (PCI)-mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells.
Peng W; Samplonius DF; de Visscher S; Roodenburg JL; Helfrich W; Witjes MJ
Lasers Surg Med; 2014 Oct; 46(8):650-8. PubMed ID: 25174329
[TBL] [Abstract][Full Text] [Related]
40. Targeted killing of colorectal cancer cell lines by a humanised IgG1 monoclonal antibody that binds to membrane-bound carcinoembryonic antigen.
Conaghan P; Ashraf S; Tytherleigh M; Wilding J; Tchilian E; Bicknell D; Mortensen NJ; Bodmer W
Br J Cancer; 2008 Apr; 98(7):1217-25. PubMed ID: 18349843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
